Hyperoxia-induced NF-κB activation occurs via a maturationally sensitive atypical pathway

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 296, Issue 3, 2009, Pages

  Wright, Clyde J ^a   Zhuang, Tiangang ^a   La, Ping ^a   Yang, Guang ^a   Dennery, Phyllis A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Apoptosis; I B

Indexed keywords

CASPASE 3; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; DNA; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; FETUS; FETUS LUNG; FETUS LUNG MATURATION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HYPEROXIA; LUNG FIBROBLAST; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; AMINO ACID SUBSTITUTION; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; CYTOLOGY; FIBROBLAST; GENE EXPRESSION; GENETICS; LUNG; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; REPORTER GENE; SITE DIRECTED MUTAGENESIS;

AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; DNA; FETUS; FIBROBLASTS; GENE EXPRESSION; GENES, REPORTER; HYPEROXIA; I-KAPPA B PROTEINS; LUCIFERASES; LUNG; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PHOSPHORYLATION; RATS; RECOMBINANT PROTEINS; TRANSFECTION; TYROSINE;

EID: 64249093444     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90499.2008     Document Type: Article

References (71)

1. Allen GL, Menendez IY, Ryan MA, Mazor RL, Wispe JR, Fiedler MA, Wong HR. Hyperoxia synergistically increases TNF-α-induced interleukin-8 gene expression in A549 cells. Am J Physiol Lung Cell Mol Physiol 278: L253-L260, 2000.
2. Alvira CM, Abate A, Yang G, Dennery PA, Rabinovitch M. NF-κB activation in the neonatal mouse lung protects against lipopolysaccharide- induced inflammation. Am J Respir Crit Care Med 175: 805-815, 2007. (Pubitemid 46631792)
3. Ankermann T, Reisner A, Wiemann T, Krams M, Kohler H, Krause MF. Topical inhibition of nuclear factor-κB enhances reduction in lung edema by surfactant in a piglet model of airway lavage. Crit Care Med 33: 1384-1391, 2005.
4. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 87: 13-20, 1996.
5. Belik J, Jankov RP, Pan J, Tanswell AK. Chronic O2 exposure enhances vascular and airway smooth muscle contraction in the newborn but not adult rat. J Appl Physiol 94: 2303-2312, 2003. (Pubitemid 36605291)
6. Bentires-Alj M, Dejardin E, Viatour P, Van Lint C, Froesch B, Reed JC, Merville MP, Bours V. Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines. Oncogene 20: 2805-2813, 2001. (Pubitemid 32549837)
7. Beraud C, Henzel WJ, Baeuerle PA. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation. Proc Natl Acad Sci USA 96: 429-434, 1999. (Pubitemid 29061225)
8. Boros LG, Torday JS, Paul Lee WN, Rehan VK. Oxygen-induced metabolic changes and transdifferentiation in immature fetal rat lung lipofibroblasts. Mol Genet Metab 77: 230-236, 2002.
9. Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, Pekna M, Hellstrom M, Gebre-Medhin S, Schalling M, Nilsson M, Kurland S, Tornell J, Heath JK, Betsholtz C. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85: 863-873, 1996. (Pubitemid 26192137)
10. Bourbia A, Cruz MA, Rozycki HJ. NF-κB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome. Arch Dis Child Fetal Neonatal Ed 91: F36-F39, 2006. (Pubitemid 43059200)
11. Breeze RG, Wheeldon EB. The cells of the pulmonary airways. Am Rev Respir Dis 116: 705-777, 1977.
12. Bruce MC, Bruce EN, Janiga K, Chetty A. Hyperoxic exposure of developing rat lung decreases tropoelastin mRNA levels that rebound postexposure. Am J Physiol Lung Cell Mol Physiol 265: L293-L300, 1993. (Pubitemid 23297393)
13. Bruce MC, Honaker CE, Cross RJ. Lung fibroblasts undergo apoptosis following alveolarization. Am J Respir Cell Mol Biol 20: 228-236, 1999.
14. Bruce MC, Pawlowski R, Tomashefski JF Jr. Changes in lung elastic fiber structure and concentration associated with hyperoxic exposure in the developing rat lung. Am Rev Respir Dis 140: 1067-1074, 1989. (Pubitemid 19259514)
15. Buccellato LJ, Tso M, Akinci OI, Chandel NS, Budinger GR. Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. J Biol Chem 279: 6753-6760, 2004. (Pubitemid 38248816)
16. Budinger GR, Tso M, McClintock DS, Dean DA, Sznajder JI, Chandel NS. Hyperoxia-induced apoptosis does not require mitochondrial reactive oxygen species and is regulated by Bcl-2 proteins. J Biol Chem 277: 15654-15660, 2002.
17. Bui NT, Livolsi A, Peyron JF, Prehn JH. Activation of nuclear factor κB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IκBα. J Cell Biol 152: 753-764, 2001. (Pubitemid 34280160)
18. Cao L, Liu C, Cai B, Jia X, Kang L, Speer CP, Sun B. Nuclear factor-κB expression in alveolar macrophages of mechanically ventilated neonates with respiratory distress syndrome. Biol Neonate 86: 116-123, 2004. (Pubitemid 39140332)
19. Cazals V, Nabeyrat E, Corroyer S, de Keyzer Y, Clement A. Role for NF-κB in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells. Biochim Biophys Acta 1448: 349-362, 1999. (Pubitemid 29070859)
20. Cheah FC, Winterbourn CC, Darlow BA, Mocatta TJ, Vissers MC. Nuclear factor κB activation in pulmonary leukocytes from infants with hyaline membrane disease: associations with chorioamnionitis and Ureaplasma urealyticum colonization. Pediatr Res 57: 616-623, 2005.
21. Chelly N, Mouhieddine-Gueddiche OB, Barlier-Mur AM, Chailley-Heu B, Bourbon JR. Keratinocyte growth factor enhances maturation of fetal rat lung type II cells. Am J Respir Cell Mol Biol 20: 423-432, 1999. (Pubitemid 129504864)
22. Christman JW, Sadikot RT, Blackwell TS. The role of nuclear factor-κB in pulmonary diseases. Chest 117: 1482-1487, 2000.
23. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66: 523-531, 1997. (Pubitemid 127470201)
24. Crapo JD, Barry BE, Foscue HA, Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 122: 123-143, 1980. (Pubitemid 10073551)
25. D'Angio CT, LoMonaco MB, Johnston CJ, Reed CK, Finkelstein JN. Differential roles for NF-κB in endotoxin and oxygen induction of interleukin-8 in the macrophage. Am J Physiol Lung Cell Mol Physiol 286: L30-L36, 2004.
26. Delemos RA, Coalson JJ, Gerstmann DR, Kuehl TJ, Null DM Jr. Oxygen toxicity in the premature baboon with hyaline membrane disease. Am Rev Respir Dis 136: 677-682, 1987.
27. Dirami G, Massaro GD, Clerch LB, Ryan US, Reczek PR, Massaro D. Lung retinol-storing cells synthesize and secrete retinoic acid, an inducer of alveolus formation. Am J Physiol Lung Cell Mol Physiol 286: L249-L256, 2004. (Pubitemid 38129504)
28. Fan C, Yang J, Engelhardt JF. Temporal pattern of NFκB activation influences apoptotic cell fate in a stimuli-dependent fashion. J Cell Sci 115: 4843-4853, 2002. (Pubitemid 36054637)
29. Franek WR, Horowitz S, Stansberry L, Kazzaz JA, Koo HC, Li Y, Arita Y, Davis JM, Mantell AS, Scott W, Mantell LL. Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J Biol Chem 276: 569-575, 2001. (Pubitemid 32050353)
30. Franek WR, Morrow DM, Zhu H, Vancurova I, Miskolci V, Darley-Usmar K, Simms HH, Mantell LL. NF-κB protects lung epithelium against hyperoxia-induced nonapoptotic cell death-oncosis. Free Radic Biol Med 37: 1670-1679, 2004. (Pubitemid 39349813)
31. Frank L, Bucher JR, Roberts RJ. Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol 45: 699-704, 1978. (Pubitemid 10209215)
32. Guthmann F, Wissel H, Schachtrup C, Tolle A, Rudiger M, Spener F, Rustow B. Inhibition of TNFα in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells. Respir Res 6: 10, 2005. (Pubitemid 41358058)
33. Han RN, Buch S, Tseu I, Young J, Christie NA, Frndova H, Lye SJ, Post M, Tanswell AK. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res 39: 921-929, 1996. (Pubitemid 26170968)
34. Hoffmann A, Baltimore D. Circuitry of nuclear factor κB signaling. Immunol Rev 210: 171-186, 2006.
35. Hokuto I, Perl AK, Whitsett JA. FGF signaling is required for pulmonary homeostasis following hyperoxia. Am J Physiol Lung Cell Mol Physiol 286: L580-L587, 2004. (Pubitemid 38233630)
36. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF. Tyrosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα. Cell 86: 787-798, 1996. (Pubitemid 26303447)
37. Janssen-Heininger YM, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med 28: 1317-1327, 2000.
38. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 3: 221-227, 2002. (Pubitemid 34213423)
39. Kilpinen S, Henttinen T, Lahdenpohja N, Hulkkonen J, Hurme M. Signals leading to the activation of NF-κB transcription factor are stronger in neonatal than adult T lymphocytes. Scand J Immunol 44: 85-88, 1996. (Pubitemid 26227460)
40. Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activation of nuclear factor κB through the phosphorylation of IκBα on tyrosine residues. Cancer Res 54: 1425-1430, 1994.
41. Kresch MJ, Christian C, Wu F, Hussain N. Ontogeny of apoptosis during lung development. Pediatr Res 43: 426-431, 1998. (Pubitemid 28101040)
42. Li Y, Zhang W, Mantell LL, Kazzaz JA, Fein AM, Horowitz S. Nuclear factor-κB is activated by hyperoxia but does not protect from cell death. J Biol Chem 272: 20646-20649, 1997. (Pubitemid 27355625)
43. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, Abman SH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58: 22-29, 2005. (Pubitemid 40967424)
44. Lindahl P, Karlsson L, Hellstrom M, Gebre-Medhin S, Willetts K, Heath JK, Betsholtz C. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development 124: 3943-3953, 1997. (Pubitemid 27483322)
45. Livolsi A, Busuttil V, Imbert V, Abraham RT, Peyron JF. Tyrosine phosphorylation-dependent activation of NF-κB. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Eur J Biochem 268: 1508-1515, 2001. (Pubitemid 32231906)
46. Mukhopadhyay A, Manna SK, Aggarwal BB. Pervanadate-induced nuclear factor-κB activation requires tyrosine phosphorylation and degradation of IκBα. Comparison with tumor necrosis factor-α. J Biol Chem 275: 8549-8555, 2000. (Pubitemid 30180203)
47. Odoms K, Shanley TP, Wong HR. Short-term modulation of interleukin-1β signaling by hyperoxia: uncoupling of IκB kinase activation and NF-κB-dependent gene expression. Am J Physiol Lung Cell Mol Physiol 286: L554-L562, 2004. (Pubitemid 38233627)
48. Piva R, Belardo G, Santoro MG. NF-κB: a stress-regulated switch for cell survival. Antioxid Redox Signal 8: 478-486, 2006. (Pubitemid 43741316)
49. Post M, Souza P, Liu J, Tseu I, Wang J, Kuliszewski M, Tanswell AK. Keratinocyte growth factor and its receptor are involved in regulating early lung branching. Development 122: 3107-3115, 1996. (Pubitemid 26371976)
50. Rahman I, Mulier B, Gilmour PS, Watchorn T, Donaldson K, Jeffery PK, MacNee W. Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear factor-κB. Biochem Pharmacol 62: 787-794, 2001. (Pubitemid 32816997)
51. Rehan V, Torday J. Hyperoxia augments pulmonary lipofibroblast-to- myofibroblast transdifferentiation. Cell Biochem Biophys 38: 239-250, 2003. (Pubitemid 41270808)
52. Roth-Kleiner M, Post M. Similarities and dissimilarities of branching and septation during lung development. Pediatr Pulmonol 40: 113-134, 2005. (Pubitemid 41099428)
53. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802-806, 1989. (Pubitemid 19056244)
54. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9: 49-89, 2007.
55. Scavo LM, Ertsey R, Chapin CJ, Allen L, Kitterman JA. Apoptosis in the development of rat and human fetal lungs. Am J Respir Cell Mol Biol 18: 21-31, 1998. (Pubitemid 128355343)
56. Schittny JC, Djonov V, Fine A, Burri PH. Programmed cell death contributes to postnatal lung development. Am J Respir Cell Mol Biol 18: 786-793, 1998. (Pubitemid 128358425)
57. Schoonbroodt S, Ferreira V, Best-Belpomme M, Boelaert JR, Legrand-Poels S, Korner M, Piette J. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of IκBα in NF-κB activation by an oxidative stress. J Immunol 164: 4292-4300, 2000. (Pubitemid 30215091)
58. Shea LM, Beehler C, Schwartz M, Shenkar R, Tuder R, Abraham E. Hyperoxia activates NF-κB and increases TNF-α and IFN-γ gene expression in mouse pulmonary lymphocytes. J Immunol 157: 3902-3908, 1996. (Pubitemid 126449298)
59. Singh S, Darnay BG, Aggarwal BB. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation. J Biol Chem 271: 31049-31054, 1996. (Pubitemid 26408542)
60. Suzuki Y, Nishio K, Takeshita K, Takeuchi O, Watanabe K, Sato N, Naoki K, Kudo H, Aoki T, Yamaguchi K. Effect of steroid on hyperoxia-induced ICAM-1 expression in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 278: L245-L252, 2000. (Pubitemid 30131208)
61. Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, Aggarwal BB. Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65: evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase. J Biol Chem 278: 24233-24241, 2003. (Pubitemid 36830260)
62. Uckun FM, Schieven GL, Tuel-Ahlgren LM, Dibirdik I, Myers DE, Ledbetter JA, Song CW. Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors. Proc Natl Acad Sci USA 90: 252-256, 1993. (Pubitemid 23010288)
63. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 105: 1194-1201, 2000.
64. Vancurova I, Bellani P, Davidson D. Activation of nuclear factor-κB and its suppression by dexamethasone in polymorphonuclear leukocytes: newborn versus adult. Pediatr Res 49: 257-262, 2001. (Pubitemid 32119224)
65. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A, Everette R, Peters N, Miller N, Muran G, Auten K, Newman N, Rowan G, Grisby C, Arnell K, Miller L, Ball B, McDavid G. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114: 1305-1311, 2004. (Pubitemid 41647693)
66. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol Lung Cell Mol Physiol 275: L110-L117, 1998.
67. Wong HR, Odoms KK, Denenberg AG, Allen GL, Shanley TP. Hyperoxia prolongs tumor necrosis factor-α-mediated activation of NF-κB: role of IκB kinase. Shock 17: 274-279, 2002.
68. Yang G, Abate A, George AG, Weng YH, Dennery PA. Maturational differences in lung NF-κB activation and their role in tolerance to hyperoxia. J Clin Invest 114: 669-678, 2004. (Pubitemid 39578757)
69. Yang G, Madan A, Dennery PA. Maturational differences in hyperoxic AP-1 activation in rat lung. Am J Physiol Lung Cell Mol Physiol 278: L393-L398, 2000. (Pubitemid 30131225)
70. Yee M, Vitiello PF, Roper JM, Staversky RJ, Wright TW, McGrath-Morrow SA, Maniscalco WM, Finkelstein JN, O'Reilly MA. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am J Physiol Lung Cell Mol Physiol 291: L1101-L1111, 2006.
71. Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor κB independently of IκB degradation. Hepatology 28: 1022-1030, 1998. (Pubitemid 28450263)